NCT05799612 2026-02-13
Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
Phase 1 Withdrawn
Clinical Trials
5 trialsNCT05729139 2023-08-09
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Baptist Health South Florida
Phase 1 Withdrawn
NCT02174172 2020-05-12
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors
Hoffmann-La Roche
Phase 1 Completed
NCT02407080 2019-09-12
Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT00253474 2012-03-29
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
National Institutes of Health Clinical Center (CC)
Phase 1 Completed